These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9642124)

  • 1. Differential expression of alternatively spliced c-erbB-2 mRNA in primary tumors, lymph node metastases, and bone marrow micrometastases from breast cancer patients.
    Gebhardt F; Zänker KS; Brandt B
    Biochem Biophys Res Commun; 1998 Jun; 247(2):319-23. PubMed ID: 9642124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
    Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
    Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
    J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of bone marrow micrometastases of breast tumors].
    Dubecz S; Csuka O; Török K; Vasas N; Péley G; Doleschal Z; Sulyok Z; Láng I; Köves I
    Magy Seb; 2003 Aug; 56(3-4):108-12. PubMed ID: 14619093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The parathyroid hormone-related protein (PTHrP) gene: use of downstream TATA promotor and PTHrP 1-139 coding pathways in primary breast cancers vary with the occurrence of bone metastasis.
    Bouizar Z; Spyratos F; De vernejoul MC
    J Bone Miner Res; 1999 Mar; 14(3):406-14. PubMed ID: 10027905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.
    Benoy IH; Salgado R; Elst H; Van Dam P; Weyler J; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
    Breast Cancer Res; 2005; 7(2):R210-9. PubMed ID: 15743502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.
    Braun S; Schlimok G; Heumos I; Schaller G; Riethdorf L; Riethmüller G; Pantel K
    Cancer Res; 2001 Mar; 61(5):1890-5. PubMed ID: 11280743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of differential PCR and immunohistochemistry for the evaluation of c-erbB-2 in breast carcinoma and relationship to other prognostic factors.
    Erdogan S; Ergin M; Tuncer I
    Neoplasma; 2003; 50(5):326-30. PubMed ID: 14628084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible predictive markers related to micro-metastasis in breast cancer patients.
    Zhu L; Loo WT; Cheng CW; Chow LW
    Oncol Rep; 2006 May; 15(5):1217-23. PubMed ID: 16596190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma.
    Matsuura K; Yamaguchi Y; Ueno H; Osaki A; Arihiro K; Toge T
    Cancer; 2006 Mar; 106(6):1227-36. PubMed ID: 16475148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of an estrogen receptor alpha variant protein in cell lines and tumors.
    Fasco MJ; Keyomarsi K; Arcaro KF; Gierthy JF
    Mol Cell Endocrinol; 2000 Aug; 166(2):156-69. PubMed ID: 11203301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular signature associated with bone marrow micrometastasis in human breast cancer.
    Woelfle U; Cloos J; Sauter G; Riethdorf L; Jänicke F; van Diest P; Brakenhoff R; Pantel K
    Cancer Res; 2003 Sep; 63(18):5679-84. PubMed ID: 14522883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A real-time one-step reverse transcriptase-polymerase chain reaction method to quantify c-erbB-2 expression in human breast cancer.
    Pawlowski V; Révillion F; Hornez L; Peyrat JP
    Cancer Detect Prev; 2000; 24(3):212-23. PubMed ID: 10975282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The detection of breast carcinoma micrometastases in axillary lymph nodes by reverse transcriptase-polymerase chain reaction].
    Zhang Q; Zhang Y; Gu X; Zhang M; Lin H; Qian H
    Zhonghua Wai Ke Za Zhi; 1998 Jul; 36(7):430-2. PubMed ID: 11825433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation.
    Aigner A; Juhl H; Malerczyk C; Tkybusch A; Benz CC; Czubayko F
    Oncogene; 2001 Apr; 20(17):2101-11. PubMed ID: 11360194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NH(2)-terminal truncated HER-2 protein but not full-length receptor is associated with nodal metastasis in human breast cancer.
    Molina MA; Sáez R; Ramsey EE; Garcia-Barchino MJ; Rojo F; Evans AJ; Albanell J; Keenan EJ; Lluch A; García-Conde J; Baselga J; Clinton GM
    Clin Cancer Res; 2002 Feb; 8(2):347-53. PubMed ID: 11839648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
    Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H
    Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive reverse transcriptase-PCR: an improved method for determination of c-erbB-2 gene expression.
    Schneeberger C; Eder S; Speiser P; Zeillinger R
    Anticancer Res; 1996; 16(2):849-52. PubMed ID: 8687140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer.
    Hengstler JG; Lange J; Kett A; Dornhöfer N; Meinert R; Arand M; Knapstein PG; Becker R; Oesch F; Tanner B
    Cancer Res; 1999 Jul; 59(13):3206-14. PubMed ID: 10397267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.